Melanie A. Leiby
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Immunology top 2%
- Cancer Research top 2%
- Molecular Biology top 10%
- Co-authors
- Andrew RobinsonMartin ReckKatsuyuki HottaNir PeledSinéad CuffeAli TafreshiDelvys Rodríguez‐AbreuReshma Rangwala
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)Lung Cancer Diagnosis and Treatment (2 papers)CRISPR and Genetic Engineering (2 papers)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Melanie A. Leiby
7 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 6.1k
- Pulmonary and Respiratory Medicine 3.9k
- Immunology 1.5k
- Cancer Research 930
- Molecular Biology 795
Countries citing papers authored by Melanie A. Leiby
This map shows the geographic impact of Melanie A. Leiby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie A. Leiby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie A. Leiby more than expected).
Fields of papers citing papers by Melanie A. Leiby
This network shows the impact of papers produced by Melanie A. Leiby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie A. Leiby. The network helps show where Melanie A. Leiby may publish in the future.
Co-authorship network of co-authors of Melanie A. Leiby
This figure shows the co-authorship network connecting the top 25 collaborators of Melanie A. Leiby. A scholar is included among the top collaborators of Melanie A. Leiby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie A. Leiby. Melanie A. Leiby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 18 | |
| 3 | 42 | |
| 4 | 12 | |
| 5 | Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancerbreakdown → | 7054 |
| 6 | 14 | |
| 7 | 72 |
About Melanie A. Leiby
Melanie A. Leiby is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 7 papers that have together received 7.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Diagnosis and Treatment (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Oncology (6.1k citations), Pulmonary and Respiratory Medicine (3.9k citations) and Immunology (1.5k citations). Melanie A. Leiby has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Andrew Robinson, Martin Reck, Katsuyuki Hotta, Nir Peled, Sinéad Cuffe, Ali Tafreshi, Delvys Rodríguez‐Abreu, Reshma Rangwala, Julie R. Brahmer and Mary O’Brien. Their work appears in journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.